Lepu Medical Technology (Beijing) Co., Ltd. (300003.SZ)
CNY 10.66
(2.3%)
CNY 10.66
(2.3%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.16 Billion | 2.79 Billion | 3.06 Billion | 2.08 Billion | 1.99 Billion | 1.5 Billion |
| Net Income | 1.25 Billion | 2.24 Billion | 1.78 Billion | 1.87 Billion | 1.72 Billion | 1.25 Billion |
| Depreciation & Amortization | 603.77 Million | 488.47 Million | 448.74 Million | 388.2 Million | 284.49 Million | 231.46 Million |
| Deferred income taxes | -62.89 Million | -13.58 Million | -66.35 Million | 29.78 Million | -20.12 Million | -47.89 Million |
| Stock-based compensation | 168.2 Million | 82.98 Million | - | - | - | - |
| Change in working capital | -1.22 Billion | -355.23 Million | 142.14 Million | -260.25 Million | -400.05 Million | -426.37 Million |
| Other non-cash items | 3.03 Billion | 343.38 Million | 690.68 Million | 84.66 Million | 382.03 Million | 440.53 Million |
| Investing Cash Flow | -1.88 Billion | -1.59 Billion | -860.46 Million | -695.45 Million | -651.21 Million | -2.32 Billion |
| Investments in PPE | -844.66 Million | -905.21 Million | -984.39 Million | -600.14 Million | -563.11 Million | -1.07 Billion |
| Acquisitions | -207.55 Million | -21.42 Million | -452.85 Million | -109.68 Million | -240.89 Million | -185.15 Million |
| Investment purchases | -634.14 Million | -723.48 Million | -171.08 Million | -482.12 Million | -404.17 Million | -1.34 Billion |
| Sales/Maturities of investments | 568.73 Million | 99.15 Million | 813.52 Million | 371.51 Million | 677.26 Million | 430.72 Million |
| Other Investing Activities | -764.84 Million | -48.35 Million | -65.66 Million | 124.98 Million | -120.29 Million | -147.51 Million |
| Financing Cash Flow | -469.83 Million | 412.74 Million | -897.4 Million | -763.43 Million | -1.54 Billion | 767.59 Million |
| Debt repayment | -441.56 Million | -2.51 Billion | -4.25 Billion | -4.79 Billion | -4.12 Billion | -2.65 Billion |
| Dividends payments | -635.05 Million | -487.98 Million | -408.61 Million | -353.85 Million | -291.92 Million | -477.13 Million |
| Common Stock Repurchased | -75.24 Million | -245.91 Million | -109.9 Million | - | -158.28 Million | -95.99 Million |
| Common Stock Issuance | - | 245.91 Million | 609.74 Million | - | 158.28 Million | - |
| Other Financing Activities | -132.94 Million | 3.56 Billion | 3.44 Billion | 4.63 Billion | 3.21 Billion | 3.89 Billion |
| Accounts receivables | 3.22 Million | -665.06 Million | 42.84 Million | -32.71 Million | -252.49 Million | -504.46 Million |
| Accounts payables | -982 Million | 710.12 Million | 660.39 Million | 165.52 Million | 78.15 Million | 213.73 Million |
| Inventory | -251.01 Million | -386.7 Million | -494.73 Million | -422.85 Million | -205.59 Million | -87.75 Million |
| Other working capital | -1.04 Billion | -13.58 Million | -66.35 Million | 29.78 Million | -20.12 Million | -338.61 Million |
| Cash at beginning of period | 5.46 Billion | 3.68 Billion | 2.39 Billion | 1.79 Billion | 1.99 Billion | 2.03 Billion |
| Cash at end of period | 4.22 Billion | 5.3 Billion | 3.68 Billion | 2.39 Billion | 1.79 Billion | 1.99 Billion |
| Capital Expenditure | -844.66 Million | -905.21 Million | -984.39 Million | -600.14 Million | -563.11 Million | -1.07 Billion |
| Effect of forex changes on cash | -20.58 Million | 21.12 Million | -11.31 Million | -31.23 Million | 4.39 Million | 19.4 Million |
| Net cash flow / Change in cash | -1.24 Billion | 1.62 Billion | 1.29 Billion | 599.57 Million | -205.42 Million | -34.5 Million |
| Free Cash Flow | 318.88 Million | 1.88 Billion | 2.07 Billion | 1.48 Billion | 1.42 Billion | 428.57 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 105.41 Million | 215.37 Million | 481.87 Million | -95.4 Million | 1.25 Billion | 392.11 Million |
| Depreciation & Amortization | - | 159.78 Million | 159.78 Million | 154.17 Million | 603.77 Million | -259.79 Million |
| Deferred income taxes | - | - | - | -228.77 Million | -62.89 Million | 226.06 Million |
| Stock-based compensation | - | 29.98 Million | - | 168.2 Million | 168.2 Million | -85.29 Million |
| Change in working capital | - | -422.82 Million | - | -247.78 Million | -1.22 Billion | -4.57 Million |
| Other non-cash items | 182.01 Million | -32.74 Million | -337.73 Million | 650.11 Million | 3.03 Billion | 193.56 Million |
| Investing Cash Flow | -161.56 Million | -643.89 Million | -282.62 Million | -871.06 Million | -1.88 Billion | -474.73 Million |
| Investments in PPE | -129.46 Million | -230.21 Million | -144.12 Million | -146.85 Million | -844.66 Million | -183.1 Million |
| Acquisitions | -4.74 Million | -83.27 Million | 15.89 Million | -211.22 Million | -207.55 Million | -227.16 Million |
| Investment purchases | -136.4 Million | -324.66 Million | -156.31 Million | -105.47 Million | -634.14 Million | -206.91 Million |
| Sales/Maturities of investments | 111 Million | 24.58 Million | 162.58 Million | 123.7 Million | 568.73 Million | 287.51 Million |
| Other Investing Activities | -1.93 Million | -30.32 Million | -160.67 Million | -531.21 Million | -764.84 Million | -145.05 Million |
| Financing Cash Flow | -363.11 Million | 169.07 Million | -52.06 Million | -12.65 Million | -469.83 Million | -152.69 Million |
| Debt repayment | -23.2 Million | -768.15 Million | -156.08 Million | -11.78 Million | -441.56 Million | -728.2 Million |
| Dividends payments | -287.7 Million | -637.82 Million | -38.68 Million | -635.05 Million | -635.05 Million | -51.68 Million |
| Common Stock Repurchased | 124.85 Million | -124.85 Million | - | -75.24 Million | -75.24 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -98.61 Million | -433.96 Million | -208.14 Million | 754.02 Million | -132.94 Million | 627.19 Million |
| Accounts receivables | - | -392.42 Million | - | 3.22 Million | 3.22 Million | -181.46 Million |
| Accounts payables | - | - | - | - | -982 Million | - |
| Inventory | - | -30.4 Million | - | -251.01 Million | -251.01 Million | 176.89 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 3.46 Billion | 4.13 Billion | 4.22 Billion | 4.86 Billion | 5.46 Billion | 4.75 Billion |
| Cash at end of period | 3.19 Billion | 3.6 Billion | 4.13 Billion | 4.22 Billion | 4.22 Billion | 4.58 Billion |
| Capital Expenditure | -129.46 Million | -230.21 Million | -144.12 Million | -146.85 Million | -844.66 Million | -183.1 Million |
| Effect of forex changes on cash | -4.45 Million | 1.22 Million | 1.66 Million | -1.65 Million | -20.58 Million | -3.37 Million |
| Net cash flow / Change in cash | -264.95 Million | -520.94 Million | -90.36 Million | -640.21 Million | -1.24 Billion | -168.71 Million |
| Free Cash Flow | 157.96 Million | -207.37 Million | 5366.00 | 253.68 Million | 318.88 Million | 278.97 Million |
WOWI
ITOCY
300990
0101
2983
NBRWF